Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: data from the Global Burden of Disease 2019 study

• Published in: European journal of preventive cardiology Vol. 31; no. 1; p. 23
• Main Authors: Lu, Wen-Long, Yuan, Jian-Hui, Liu, Ze-Ye, Su, Zhan-Hao, Shen, Yu-Chun, Li, Shou-Jun, Zhang, Hao
• Format: Journal Article
• Language: English
• Published: England 05.01.2024
• Subjects: Age Distribution; Aged; Bayes Theorem; Global Burden of Disease; Global Health; Heart Diseases - diagnosis; Humans; Hypertension - diagnosis; Middle Aged; Quality-Adjusted Life Years; Age–period–cohort analysis; Global Burden of Disease 2019 study; Hypertensive heart disease; Mortality trends
• ISSN: 2047-4881
• DOI: 10.1093/eurjpc/zwad262

This study aims to analyse the worldwide trends in hypertensive heart disease (HHD) mortality and associations with age, period, and birth cohort and predict the future burden of HHD deaths. Mortality estimates were obtained from Global Burden of Disease 2019 study. We used age-period-cohort (APC) model to examine the age, period, and cohort effects on HHD mortality between 1990 and 2019. Bayesian APC model was utilized to predict HHD deaths to 2034. The global HHD deaths were 1.16 million in 2019 and were projected to increase to 1.57 million in 2034, with the largest increment in low- and middle-income countries (LMICs). Between 1990 and 2019, middle/high-middle socio-demographic index (SDI) countries had the largest mortality reductions (annual percentage change = -2.06%), whereas low SDI countries saw a lagging performance (annual percentage change = -1.09%). There was a prominent transition in the age distribution of deaths towards old-age population in middle/high-middle SDI countries, while the proportion of premature deaths (aged under 60 years) remained at 24% in low SDI countries in 2019. Amongst LMICs, Brazil, China, and Ethiopia showed typically improving trends both over time and in recent birth cohorts, whereas 63 countries including Indonesia, the Philippines, and Pakistan had unfavourable or worsening risks for recent periods and birth cohorts. The HHD death burden in 2019 is vast and is expected to increase rapidly in the next decade, particularly for LMICs. Limited progress in HHD management together with high premature mortality would exact huge human and medical costs in low SDI countries. The examples from Brazil, China, and Ethiopia suggest that efficient health systems with action on improving hypertension care can reduce HHD mortality effectively in LMICs.